The Clorox Company $CLX Shares Purchased by Evelyn Partners Investment Management Services Ltd

Evelyn Partners Investment Management Services Ltd raised its holdings in The Clorox Company (NYSE:CLX) by 1,498.6% during the second quarter, Holdings Channel.com reports. The firm owned 1,135 shares of the company’s stock after purchasing an additional 1,064 shares during the quarter. Evelyn Partners Investment Management Services Ltd’s holdings in Clorox were worth $136,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of CLX. American National Bank & Trust lifted its holdings in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares during the period. NewSquare Capital LLC lifted its holdings in Clorox by 567.6% in the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after acquiring an additional 193 shares during the period. Hantz Financial Services Inc. purchased a new stake in shares of Clorox during the 2nd quarter worth $31,000. Ransom Advisory Ltd acquired a new position in shares of Clorox during the 1st quarter worth $35,000. Finally, MTM Investment Management LLC purchased a new position in shares of Clorox in the 2nd quarter valued at about $37,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Wells Fargo & Company decreased their price objective on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $152.00 price objective on shares of Clorox in a research note on Tuesday, November 4th. The Goldman Sachs Group reduced their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. Finally, Barclays dropped their price target on Clorox from $112.00 to $108.00 and set an “underweight” rating for the company in a research report on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $125.69.

Clorox Stock Performance

Clorox stock opened at $104.09 on Friday. The Clorox Company has a fifty-two week low of $98.20 and a fifty-two week high of $171.37. The company has a market capitalization of $12.70 billion, a price-to-earnings ratio of 15.96, a PEG ratio of 0.92 and a beta of 0.52. The stock has a fifty day moving average of $115.29 and a two-hundred day moving average of $122.38. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter last year, the company earned $1.86 earnings per share. The business’s revenue for the quarter was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is currently 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.